Part Details | VARICELLA-ZOSTER VI
6505-01-616-6719
Alternate Parts: 410221, 6505NCM138935, ZOSTER, NDC00006496300, NDC00006-4963-00, 6505-01-616-6719, 01-616-6719, 6505016166719, 016166719
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-616-6719
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| 410221 | 89875 | DEFENSE LOGISTICS AGENCYDIRECTORATE OF MEDICAL MATERIEL |
| 6505NCM138935 | 64616 | DEFENSE MEDICAL STANDARDIZATIONBOARD |
| ZOSTER | 0WKL3 | MERCK AND CO INCWEST POINT PHARMA DIV |
| NDC00006-4963-00 | 0WKL3 | MERCK AND CO INCWEST POINT PHARMA DIV |
Technical Data | NSN 6505-01-616-6719
| Characteristic | Specifications |
|---|---|
| SPECIAL FEATURES | LYOPHILIZED PREPARATION OF LIVE, ATTENUATED VARICELLA-ZOSTER VIRUS (OKA/MERCK); KEEP FROZEN; REQUIRES RECONSTITUTION WITH STERILE DILUENT TO GIVE A SINGLE 0.65 ML DOSE WHEN RECONSTITUTED WHEN STORED AT ROOM TEMPERATURE FOR UP TO 30 MINUTES WITH A MINIMUM OF 19,400 PFU (PLAQUE FORMING UNITS) FOR SUBCUTANEOUS INJECTION; 1 SINGLE DOSE VIAL OF LYOPHILIZED VACCINE (PACKAGE A) AND A SEPARATE PACKAGE OF 10 VIALS OF DILUENT (PACKAGE B) |
| PROTECTIVE STORAGE FEATURE | MUST BE FROZEN |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ZOSTAVAX SUSPENSION FOR INJECTION |